Journals / Dicle Tıp Dergisi / 2022 / Cilt: 49 Sayı: 1

Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion

Muhammed Demir(DICLE UNIVERSITY)
Mehmet Özbek(DICLE UNIVERSITY)
Adem Aktan(MARDIN ARTUKLU UNIVERSITY, MARDİN RESEARCH CENTER)
Tuncay Güzel(UNIVERSITY OF HEALTH SCIENCES, DİYARBAKIR GAZİ YAŞARGİL HEALTH RESEARCH CENTER)
Burhan Aslan(UNIVERSITY OF HEALTH SCIENCES, DİYARBAKIR GAZİ YAŞARGİL HEALTH RESEARCH CENTER)
Hakkı Şimşek(DICLE UNIVERSITY)
Pages
12–20
Publication Date
2022-03-11
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: As a simple, easy applicable and universal marker, MHR may be a parameter that predicts mortality risk and survival time in CTO patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Monocyte to high-density lipoprotein ratio (MHR) is a biomarker of inflammatory response.
📊
Key Findings & Data:Method: Retrospective observational study including 493 patients over a follow up period of 73 months.
💡
Conclusion & Impact:Conclusions: As a simple, easy applicable and universal marker, MHR may be a parameter that predicts mortality risk and survival time in CTO patients.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Prognosis · inflammation · mortality

Abstract

Objective: Monocyte to high-density lipoprotein ratio (MHR) is a biomarker of inflammatory response. In this study, we investigated the relationship between MHR and mortality in patients with chronic coronary artery occlusion (CTO). Method: Retrospective observational study including 493 patients over a follow up period of 73 months. Blood samples were taken before cardiac catheterization for coronary angiography. Results: Median follow-up was 48 months(26-73) . Patients were seperated into two groups: (I) MHR <17.68 (n=278, 95 females) and (II) MHR ≥17.68 (n=215, 45 females). Mortality was considerably higher in MHR II than in MHR I (n=70 vs. n=43; p<0,001). MHR was an independent predictor of mortality (OR: 1.089, 95% [CI]: 1.055-1.124, p<0,001). Lower survival rates were found in MHR II on Kaplan-Meier analyses when compared to that of MHR I (75.223±2.670 vs. 89.220±2.102, p<0,001). Conclusions: As a simple, easy applicable and universal marker, MHR may be a parameter that predicts mortality risk and survival time in CTO patients.

🔖

Cite This Article

Demir, M., Özbek, M., Aktan, A., Güzel, T., Aslan, B., Şimşek, H. (2022). Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. Dicle Tıp Dergisi, Cilt: 49 Sayı: 1, 12–20. https://doi.org/10.5798/dicletip.1085926

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Fefer P, Knudtson ML, Cheema AN, et all. Currentperspectives on coronary chronic total occlusions:the Canadian Multicenter Chronic Total OcclusionsRegistry. J Am Coll Cardiol 2012; 59: 991–7.
  2. Jeroudi OM, Alomar ME, Michael TT, et all.Prevalence and management of coronary chronictotal occlusions in a tertiary Veterans Affairshospital. Catheter Cardiovasc Interv 2014; 84:637–43.
  3. Stone GW, Kandzari DE, Mehran R, et all.Percutaneous recanalization of chronically occludedcoronary arteries: a consensus document: part I.Circulation 2005; 112:2364–72.